1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Generics
2.1. Industry Outlook
3 Generics in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Generics in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Generics in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Generics in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Generics in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Sun Pharmaceutical Industries Ltd
13.2. Viatris Inc
13.3. Novartis AG
13.4. Teva Pharmaceutical Industries Ltd
13.5. Sandoz Group AG
13.6. Hikma Pharmaceuticals Plc
13.7. Sanofi
13.8. Les Laboratoires Servier SAS
13.9. Stada Arzneimittel AG
13.10. Bayer AG
13.11. Lupin Ltd
13.12. Aspen Pharmacare Holdings Ltd
13.13. EMS SA
13.14. Eurofarma Laboratorios SA
13.15. Ache Laboratorios Farmaceuticos SA
13.16. Sino Biopharmaceutical Ltd
13.17. Hansoh Pharmaceutical Group Co Ltd
13.18. CSPC Pharmaceutical Group Ltd
13.19. Dr. Reddy's Laboratories Ltd
13.20. Cipla Ltd
13.21. Aurobindo Pharma Ltd
13.22. PT Indofarma Tbk
13.23. PT Sanbe Farma
13.24. PT Kalbe Farma Tbk
13.25. PT Soho Global Health Tbk
13.26. Friulchem SpA
13.27. DOC Generici SRL
13.28. Recordati SpA
13.29. Daiichi Sankyo Co Ltd
13.30. Sawai Group Holdings Co Ltd
13.31. Toho Holdings Co Ltd
13.32. Towa Pharmaceutical Co Ltd
13.33. Laboratorios Silanes SA de CV
13.34. Pfizer Inc
13.35. Bluefish Pharmaceuticals AB
13.36. AstraZeneca Plc
13.37. Navamedic ASA
13.38. Beacons Pharmaceuticals Pte Ltd
13.39. Abbott Laboratories SA
13.40. Adcock Ingram Holdings Ltd
13.41. Dongkook Pharmaceutical Co Ltd
13.42. JW Holdings Corp
13.43. Hanmi Pharmaceuticals Co Ltd
13.44. Dong Wha Pharma Co Ltd
13.45. Esteve Pharmaceuticals SA
13.46. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
13.47. Deva Holding AS
13.48. Apotex Inc
13.49. Pharmstandard
13.50. Biocad
13.51. R-Pharm
14 Appendix
14.1. Methodology
14.2. About the Publisher
List of Tables
Table 1: Top 5 emerging countries generics industry, revenue ($m), 2020-29
Table 2: Top 5 emerging countries generics industry, revenue ($m), 2020-24
Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2024-29
Table 4: South Africa generics market value: $ million, 2019-24
Table 5: South Africa generics market volume: % of total pharma volume, 2019-24
Table 6: South Africa generics market geography segmentation: $ million, 2024
Table 7: South Africa generics market value forecast: $ million, 2024-29
Table 8: South Africa generics market volume forecast: % of total pharma volume, 2024-29
Table 9: South Africa Size of Population (Million), 2020-24
Table 10: South Africa Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 11: South Africa GDP (Current Prices, $ Billion), 2020-24
Table 12: South Africa Inflation, 2020-24
Table 13: South Africa Consumer Price Index (Absolute), 2020-24
Table 14: South Africa Exchange Rate, 2019-24
Table 15: Brazil generics market value: $ million, 2019-24
Table 16: Brazil generics market volume: % of total pharma volume, 2019-24
Table 17: Brazil generics market geography segmentation: $ million, 2024
Table 18: Brazil generics market value forecast: $ million, 2024-29
Table 19: Brazil generics market volume forecast: % of total pharma volume, 2024-29
Table 20: Brazil Size of Population (Million), 2020-24
Table 21: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: Brazil GDP (Current Prices, $ Billion), 2020-24
Table 23: Brazil Inflation, 2020-24
Table 24: Brazil Consumer Price Index (Absolute), 2020-24
Table 25: Brazil Exchange Rate, 2019-24
Table 26: China generics market value: $ million, 2019-24
Table 27: China generics market volume: % of total pharma volume, 2019-24
Table 28: China generics market geography segmentation: $ million, 2024
Table 29: China generics market value forecast: $ million, 2024-29
Table 30: China generics market volume forecast: % of total pharma volume, 2024-29
Table 31: China Size of Population (Million), 2020-24
Table 32: China Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 33: China GDP (Current Prices, $ Billion), 2020-24
Table 34: China Inflation, 2020-24
Table 35: China Consumer Price Index (Absolute), 2020-24
Table 36: China Exchange Rate, 2019-24
Table 37: India generics market value: $ million, 2019-24
Table 38: India generics market volume: % of total pharma volume, 2019-24
Table 39: India generics market geography segmentation: $ million, 2024
Table 40: India generics market value forecast: $ million, 2024-29
Table 41: India generics market volume forecast: % of total pharma volume, 2024-29
Table 42: India Size of Population (Million), 2020-24
Table 43: India Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 44: India GDP (Current Prices, $ Billion), 2020-24
Table 45: India Inflation, 2020-24
Table 46: India Consumer Price Index (Absolute), 2020-24
Table 47: India Exchange Rate, 2019-24
Table 48: Mexico generics market value: $ million, 2019-24
Table 49: Mexico generics market volume: % of total pharma volume, 2019-24
Table 50: Mexico generics market geography segmentation: $ million, 2024
Table 51: Mexico generics market value forecast: $ million, 2024-29
Table 52: Mexico generics market volume forecast: % of total pharma volume, 2024-29
Table 53: Mexico Size of Population (Million), 2020-24
Table 54: Mexico Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 55: Mexico GDP (Current Prices, $ Billion), 2020-24
Table 56: Mexico Inflation, 2020-24
Table 57: Mexico Consumer Price Index (Absolute), 2020-24
Table 58: Mexico Exchange Rate, 2019-24
Table 59: Sun Pharmaceutical Industries Ltd: Key Facts
Table 60: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 61: Sun Pharmaceutical Industries Ltd: Key Employees
Table 62: Viatris Inc: Key Facts
Table 63: Viatris Inc: Annual Financial Ratios
Table 64: Viatris Inc: Key Employees
Table 65: Novartis AG: Key Facts
Table 66: Novartis AG: Annual Financial Ratios
Table 67: Novartis AG: Key Employees
Table 68: Teva Pharmaceutical Industries Ltd: Key Facts
Table 69: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 70: Teva Pharmaceutical Industries Ltd: Key Employees
Table 71: Sandoz Group AG: Key Facts
Table 72: Sandoz Group AG: Annual Financial Ratios
Table 73: Sandoz Group AG: Key Employees
Table 74: Hikma Pharmaceuticals Plc: Key Facts
Table 75: Hikma Pharmaceuticals Plc: Annual Financial Ratios
Table 76: Hikma Pharmaceuticals Plc: Key Employees
Table 77: Sanofi: Key Facts
Table 78: Sanofi: Annual Financial Ratios
Table 79: Sanofi: Key Employees
Table 80: Sanofi: Key Employees Continued
Table 81: Les Laboratoires Servier SAS: Key Facts
Table 82: Les Laboratoires Servier SAS: Key Employees
Table 83: Stada Arzneimittel AG: Key Facts
Table 84: Stada Arzneimittel AG: Key Employees
Table 85: Bayer AG: Key Facts
Table 86: Bayer AG: Annual Financial Ratios
Table 87: Bayer AG: Key Employees
Table 88: Bayer AG: Key Employees Continued
Table 89: Bayer AG: Key Employees Continued
Table 90: Lupin Ltd: Key Facts
Table 91: Lupin Ltd: Annual Financial Ratios
Table 92: Lupin Ltd: Key Employees
Table 93: Aspen Pharmacare Holdings Ltd: Key Facts
Table 94: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 95: Aspen Pharmacare Holdings Ltd: Key Employees
Table 96: EMS SA: Key Facts
Table 97: EMS SA: Key Employees
Table 98: Eurofarma Laboratorios SA: Key Facts
Table 99: Eurofarma Laboratorios SA: Key Employees
Table 100: Ache Laboratorios Farmaceuticos SA: Key Facts
Table 101: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 102: Sino Biopharmaceutical Ltd: Key Facts
Table 103: Sino Biopharmaceutical Ltd: Annual Financial Ratios
Table 104: Sino Biopharmaceutical Ltd: Key Employees
Table 105: Hansoh Pharmaceutical Group Co Ltd: Key Facts
Table 106: Hansoh Pharmaceutical Group Co Ltd: Annual Financial Ratios
Table 107: Hansoh Pharmaceutical Group Co Ltd: Key Employees
Table 108: CSPC Pharmaceutical Group Ltd: Key Facts
Table 109: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
Table 110: CSPC Pharmaceutical Group Ltd: Key Employees
Table 111: Dr. Reddy's Laboratories Ltd: Key Facts
Table 112: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
Table 113: Dr. Reddy's Laboratories Ltd: Key Employees
Table 114: Cipla Ltd: Key Facts
Table 115: Cipla Ltd: Annual Financial Ratios
Table 116: Cipla Ltd: Key Employees
Table 117: Aurobindo Pharma Ltd: Key Facts
Table 118: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 119: Aurobindo Pharma Ltd: Key Employees
Table 120: Aurobindo Pharma Ltd: Key Employees Continued
Table 121: PT Indofarma Tbk: Key Facts
Table 122: PT Indofarma Tbk: Annual Financial Ratios
Table 123: PT Sanbe Farma: Key Facts
Table 124: PT Sanbe Farma: Key Employees
Table 125: PT Kalbe Farma Tbk: Key Facts
Table 126: PT Kalbe Farma Tbk: Annual Financial Ratios
Table 127: PT Kalbe Farma Tbk: Key Employees
Table 128: PT Soho Global Health Tbk: Key Facts
Table 129: PT Soho Global Health Tbk: Annual Financial Ratios
Table 130: PT Soho Global Health Tbk: Key Employees
Table 131: Friulchem SpA: Key Facts
Table 132: Friulchem SpA: Key Employees
Table 133: DOC Generici SRL: Key Facts
Table 134: DOC Generici SRL: Key Employees
Table 135: Recordati SpA: Key Facts
Table 136: Recordati SpA: Annual Financial Ratios
Table 137: Recordati SpA: Key Employees
Table 138: Daiichi Sankyo Co Ltd: Key Facts
Table 139: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 140: Daiichi Sankyo Co Ltd: Key Employees
Table 141: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 142: Sawai Group Holdings Co Ltd: Key Facts
Table 143: Sawai Group Holdings Co Ltd: Annual Financial Ratios
Table 144: Sawai Group Holdings Co Ltd: Key Employees
Table 145: Toho Holdings Co Ltd: Key Facts
Table 146: Toho Holdings Co Ltd: Annual Financial Ratios
Table 147: Toho Holdings Co Ltd: Key Employees
Table 148: Towa Pharmaceutical Co Ltd: Key Facts
Table 149: Towa Pharmaceutical Co Ltd: Annual Financial Ratios
Table 150: Towa Pharmaceutical Co Ltd: Key Employees
Table 151: Towa Pharmaceutical Co Ltd: Key Employees Continued
Table 152: Laboratorios Silanes SA de CV: Key Facts
Table 153: Pfizer Inc: Key Facts
Table 154: Pfizer Inc: Annual Financial Ratios
Table 155: Pfizer Inc: Key Employees
Table 156: Pfizer Inc: Key Employees Continued
Table 157: Bluefish Pharmaceuticals AB: Key Facts
Table 158: Bluefish Pharmaceuticals AB: Key Employees
Table 159: AstraZeneca Plc: Key Facts
Table 160: AstraZeneca Plc: Annual Financial Ratios
Table 161: AstraZeneca Plc: Key Employees
Table 162: Navamedic ASA: Key Facts
Table 163: Navamedic ASA: Annual Financial Ratios
Table 164: Navamedic ASA: Key Employees
Table 165: Beacons Pharmaceuticals Pte Ltd: Key Facts
Table 166: Abbott Laboratories SA: Key Facts
Table 167: Adcock Ingram Holdings Ltd: Key Facts
Table 168: Adcock Ingram Holdings Ltd: Key Employees
Table 169: Dongkook Pharmaceutical Co Ltd: Key Facts
Table 170: Dongkook Pharmaceutical Co Ltd: Annual Financial Ratios
Table 171: Dongkook Pharmaceutical Co Ltd: Key Employees
Table 172: JW Holdings Corp: Key Facts
Table 173: JW Holdings Corp: Annual Financial Ratios
Table 174: JW Holdings Corp: Key Employees
Table 175: Hanmi Pharmaceuticals Co Ltd: Key Facts
Table 176: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 177: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 178: Dong Wha Pharma Co Ltd: Key Facts
Table 179: Dong Wha Pharma Co Ltd: Annual Financial Ratios
Table 180: Dong Wha Pharma Co Ltd: Key Employees
Table 181: Esteve Pharmaceuticals SA: Key Facts
Table 182: Esteve Pharmaceuticals SA: Key Employees
Table 183: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Facts
Table 184: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 185: Deva Holding AS: Key Facts
Table 186: Deva Holding AS: Annual Financial Ratios
Table 187: Deva Holding AS: Key Employees
Table 188: Apotex Inc: Key Facts
Table 189: Apotex Inc: Key Employees
Table 190: Pharmstandard: Key Facts
Table 191: Pharmstandard: Key Employees
Table 192: Biocad: Key Facts
Table 193: Biocad: Key Employees
Table 194: R-Pharm: Key Facts
Table 195: R-Pharm: Key Employees
List of Figures
Figure 1: Top 5 emerging countries generics industry, revenue ($m), 2020-29
Figure 2: Top 5 emerging countries generics industry, revenue ($m), 2020-24
Figure 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2024-29
Figure 4: South Africa generics market value: $ million, 2019-24
Figure 5: South Africa generics market volume: % of total pharma volume, 2019-24
Figure 6: South Africa generics market geography segmentation: % share, by value, 2024
Figure 7: South Africa generics market value forecast: $ million, 2024-29
Figure 8: South Africa generics market volume forecast: % of total pharma volume, 2024-29
Figure 9: Forces driving competition in the generics market in South Africa, 2024
Figure 10: Drivers of buyer power in the generics market in South Africa, 2024
Figure 11: Drivers of supplier power in the generics market in South Africa, 2024
Figure 12: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2024
Figure 13: Factors influencing the threat of substitutes in the generics market in South Africa, 2024
Figure 14: Drivers of degree of rivalry in the generics market in South Africa, 2024
Figure 15: Brazil generics market value: $ million, 2019-24
Figure 16: Brazil generics market volume: % of total pharma volume, 2019-24
Figure 17: Brazil generics market geography segmentation: % share, by value, 2024
Figure 18: Brazil generics market value forecast: $ million, 2024-29
Figure 19: Brazil generics market volume forecast: % of total pharma volume, 2024-29
Figure 20: Forces driving competition in the generics market in Brazil, 2024
Figure 21: Drivers of buyer power in the generics market in Brazil, 2024
Figure 22: Drivers of supplier power in the generics market in Brazil, 2024
Figure 23: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2024
Figure 24: Factors influencing the threat of substitutes in the generics market in Brazil, 2024
Figure 25: Drivers of degree of rivalry in the generics market in Brazil, 2024
Figure 26: China generics market value: $ million, 2019-24
Figure 27: China generics market volume: % of total pharma volume, 2019-24
Figure 28: China generics market geography segmentation: % share, by value, 2024
Figure 29: China generics market value forecast: $ million, 2024-29
Figure 30: China generics market volume forecast: % of total pharma volume, 2024-29
Figure 31: Forces driving competition in the generics market in China, 2024
Figure 32: Drivers of buyer power in the generics market in China, 2024
Figure 33: Drivers of supplier power in the generics market in China, 2024
Figure 34: Factors influencing the likelihood of new entrants in the generics market in China, 2024
Figure 35: Factors influencing the threat of substitutes in the generics market in China, 2024
Figure 36: Drivers of degree of rivalry in the generics market in China, 2024
Figure 37: India generics market value: $ million, 2019-24
Figure 38: India generics market volume: % of total pharma volume, 2019-24
Figure 39: India generics market geography segmentation: % share, by value, 2024
Figure 40: India generics market value forecast: $ million, 2024-29
Figure 41: India generics market volume forecast: % of total pharma volume, 2024-29
Figure 42: Forces driving competition in the generics market in India, 2024
Figure 43: Drivers of buyer power in the generics market in India, 2024
Figure 44: Drivers of supplier power in the generics market in India, 2024
Figure 45: Factors influencing the likelihood of new entrants in the generics market in India, 2024
Figure 46: Factors influencing the threat of substitutes in the generics market in India, 2024
Figure 47: Drivers of degree of rivalry in the generics market in India, 2024
Figure 48: Mexico generics market value: $ million, 2019-24
Figure 49: Mexico generics market volume: % of total pharma volume, 2019-24
Figure 50: Mexico generics market geography segmentation: % share, by value, 2024
Figure 51: Mexico generics market value forecast: $ million, 2024-29
Figure 52: Mexico generics market volume forecast: % of total pharma volume, 2024-29
Figure 53: Forces driving competition in the generics market in Mexico, 2024
Figure 54: Drivers of buyer power in the generics market in Mexico, 2024
Figure 55: Drivers of supplier power in the generics market in Mexico, 2024
Figure 56: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2024
Figure 57: Factors influencing the threat of substitutes in the generics market in Mexico, 2024
Figure 58: Drivers of degree of rivalry in the generics market in Mexico, 2024
